Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 3 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2023 Filed Oct 4, 2023 20:22 UTC |
Kaye MarkEVP & CFO Designate
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,076 | $0.00 Strike: $440.19 | $0.00 |
DisclosureSEC source: 0001156039-23-000104 · wk-form4_1696450904.xml · derivative · entry 3 Kaye Mark · CIK 0001748691 · EVP & CFO Designate 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,076 Underlying: Common Stock · 8,076 shares Expires 2033-10-02 F3 · derivative.exercise_date: The option represents a right to purchase a total of 8,076 shares, and is exercisable in three annual installments of 2,692 shares each, beginning on 10/2/2024, which is the one-year anniversary of the option grant date. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:22 UTC |
Kaye MarkEVP & CFO Designate
|
GrantCommon Stock | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000104 · wk-form4_1696450904.xml · nonDerivative · entry 2 Kaye Mark · CIK 0001748691 · EVP & CFO Designate 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,276 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 700 shares on 10/2/2024 and 701 shares each on 10/2/2025 and 10/2/2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:22 UTC |
Kaye MarkEVP & CFO Designate
|
GrantCommon Stock | 18,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000104 · wk-form4_1696450904.xml · nonDerivative · entry 1 Kaye Mark · CIK 0001748691 · EVP & CFO Designate 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,174 F1 · shares: Represents restricted share units. Restrictions lapse as follows: 6,058 shares each on 10/2/2024, 10/2/2025 and 10/2/2026. Read SEC document |
| July 21, 2023 Filed Jul 21, 2023 21:01 UTC |
Dixon Robert L JRDirector
|
SaleCommon Stock | 310 | $476.71 | $147,780.10 |
DisclosureSEC source: 0001156039-23-000090 · wk-form4_1689973249.xml · nonDerivative · entry 1 Dixon Robert L JR · CIK 0001524849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,638 Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:33 UTC |
PERU RAMIRO GDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000077 · wf-form4_168392356267941.xml · nonDerivative · entry 1 PERU RAMIRO G · CIK 0001192045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,862 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:30 UTC |
HAY LEWIS IIIDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000076 · wf-form4_168392342399557.xml · nonDerivative · entry 1 HAY LEWIS III · CIK 0001182705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,518 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:28 UTC |
Dixon Robert L JRDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000075 · wf-form4_168392331012792.xml · nonDerivative · entry 1 Dixon Robert L JR · CIK 0001524849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,948 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:24 UTC |
Neri Antonio FDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000074 · wf-form4_168392305353316.xml · nonDerivative · entry 1 Neri Antonio F · CIK 0001648401 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,936 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:23 UTC |
Schneider Ryan M.Director
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000073 · wf-form4_168392296849310.xml · nonDerivative · entry 1 Schneider Ryan M. · CIK 0001420501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,611 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC |
Jallal BahijaDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000072 · wf-form4_168392290042931.xml · nonDerivative · entry 1 Jallal Bahija · CIK 0001730038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,799 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:20 UTC |
Tallett Elizabeth EDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000071 · wf-form4_168392281515177.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,903 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:18 UTC |
STRABLE-SOETHOUT DEANNA DDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000070 · wf-form4_168392271567378.xml · nonDerivative · entry 1 STRABLE-SOETHOUT DEANNA D · CIK 0001278726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 657 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:17 UTC |
CLARK R KERRYDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000069 · wf-form4_168392263699904.xml · nonDerivative · entry 1 CLARK R KERRY · CIK 0001180776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,651 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:13 UTC |
DeVore Susan D.Director
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000068 · wf-form4_168392236656136.xml · nonDerivative · entry 1 DeVore Susan D. · CIK 0001587697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,313 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:20 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
SaleCommon Stock | 3,625 | $446.06 | $1,616,967.50 |
DisclosureSEC source: 0001156039-23-000037 · wf-form4_167994840129047.xml · nonDerivative · entry 6 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,435 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F7 · price: This transaction was executed in multiple trades at prices ranging from $445.73 to $446.42. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:20 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
SaleCommon Stock | 5,573 | $445.30 | $2,481,656.90 |
DisclosureSEC source: 0001156039-23-000037 · wf-form4_167994840129047.xml · nonDerivative · entry 5 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,060 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $444.73 to $445.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:20 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
SaleCommon Stock | 3,000 | $444.33 | $1,332,990.00 |
DisclosureSEC source: 0001156039-23-000037 · wf-form4_167994840129047.xml · nonDerivative · entry 4 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,633 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $443.73 to $444.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:20 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
SaleCommon Stock | 1,800 | $443.27 | $797,886.00 |
DisclosureSEC source: 0001156039-23-000037 · wf-form4_167994840129047.xml · nonDerivative · entry 3 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,633 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $442.71 to $443.67. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:20 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
SaleCommon Stock | 500 | $442.02 | $221,010.00 |
DisclosureSEC source: 0001156039-23-000037 · wf-form4_167994840129047.xml · nonDerivative · entry 2 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,433 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $441.60 to $442.55. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:20 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
SaleCommon Stock | 600 | $440.78 | $264,468.00 |
DisclosureSEC source: 0001156039-23-000037 · wf-form4_167994840129047.xml · nonDerivative · entry 1 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,933 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $440.36 to $441.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:32 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
SaleCommon Stock | 2,314 | $462.22 | $1,069,577.08 |
DisclosureSEC source: 0001156039-23-000033 · wf-form4_167873951013979.xml · nonDerivative · entry 1 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,327 Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:28 UTC |
Penczek Ronald WCAO & Controller
|
Tax withholdingCommon Stock | 380 | $468.78 | $178,136.40 |
DisclosureSEC source: 0001156039-23-000031 · wf-form4_167787883238771.xml · nonDerivative · entry 4 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,882 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F4 · balance_after: Balance includes 3.60 shares acquired on March 25, 2022, 3.67 shares acquired on June 24, 2022, 3.80 shares acquired on September 23, 2022 and 3.46 shares acquired on December 21, 2022 through a dividend reinvestment plan. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:24 UTC |
Norwood Felicia FEVP & President, GBD
|
Tax withholdingCommon Stock | 4,754 | $468.78 | $2,228,580.12 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,443 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:22 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
Tax withholdingCommon Stock | 5,430 | $468.78 | $2,545,475.40 |
DisclosureSEC source: 0001156039-23-000028 · wf-form4_167787850255478.xml · nonDerivative · entry 4 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,533 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:19 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
Tax withholdingCommon Stock | 1,084 | $468.78 | $508,157.52 |
DisclosureSEC source: 0001156039-23-000027 · wf-form4_167787832892336.xml · nonDerivative · entry 4 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,641 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
Tax withholdingCommon Stock | 5,469 | $468.78 | $2,563,757.82 |
DisclosureSEC source: 0001156039-23-000026 · wf-form4_167787821928724.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,893 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:15 UTC |
Gallina John EEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 4,650 | $468.78 | $2,179,827.00 |
DisclosureSEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,725 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:13 UTC |
BOUDREAUX GAILDirector · President and CEO
|
Tax withholdingCommon Stock | 17,614 | $468.78 | $8,257,090.92 |
DisclosureSEC source: 0001156039-23-000024 · wf-form4_167787796641640.xml · nonDerivative · entry 4 BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,863 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F4 · balance_after: Balance includes 236.42 shares acquired on December 21, 2022 through a dividend reinvestment plan. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:28 UTC |
Penczek Ronald WCAO & Controller
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 819 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000031 · wf-form4_167787883238771.xml · derivative · entry 5 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 819 Underlying: Common Stock · 819 shares Expires 2033-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 819 shares, and is exercisable in three installments of 273 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:28 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 1,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000031 · wf-form4_167787883238771.xml · nonDerivative · entry 3 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,262 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:28 UTC |
Penczek Ronald WCAO & Controller
|
GrantCommon Stock | 214 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000031 · wf-form4_167787883238771.xml · nonDerivative · entry 2 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,067 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 71 shares each on 3/1/2024 and 3/1/2025 and 72 shares on 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:28 UTC |
Penczek Ronald WCAO & Controller
|
Tax withholdingCommon Stock | 64 | $469.03 | $30,017.92 |
DisclosureSEC source: 0001156039-23-000031 · wf-form4_167787883238771.xml · nonDerivative · entry 1 Penczek Ronald W · CIK 0001659075 · CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,853 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:25 UTC |
Todt Blair WilliamsEVP and Chief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,195 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000030 · wf-form4_167787872030049.xml · derivative · entry 4 Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,195 Underlying: Common Stock · 8,195 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:25 UTC |
Todt Blair WilliamsEVP and Chief Legal Officer
|
GrantCommon Stock | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000030 · wf-form4_167787872030049.xml · nonDerivative · entry 3 Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,628 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 12/1/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:25 UTC |
Todt Blair WilliamsEVP and Chief Legal Officer
|
GrantCommon Stock | 2,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000030 · wf-form4_167787872030049.xml · nonDerivative · entry 2 Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,044 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:25 UTC |
Todt Blair WilliamsEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 372 | $469.03 | $174,479.16 |
DisclosureSEC source: 0001156039-23-000030 · wf-form4_167787872030049.xml · nonDerivative · entry 1 Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC |
Norwood Felicia FEVP & President, GBD
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,812 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · derivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,812 Underlying: Common Stock · 8,812 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC |
Norwood Felicia FEVP & President, GBD
|
GrantCommon Stock | 9,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,197 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC |
Norwood Felicia FEVP & President, GBD
|
GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,481 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC |
Norwood Felicia FEVP & President, GBD
|
Tax withholdingCommon Stock | 495 | $469.03 | $232,169.85 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,189 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:22 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,195 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000028 · wf-form4_167787850255478.xml · derivative · entry 5 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,195 Underlying: Common Stock · 8,195 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:22 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantCommon Stock | 9,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000028 · wf-form4_167787850255478.xml · nonDerivative · entry 3 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,963 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:22 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
GrantCommon Stock | 2,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000028 · wf-form4_167787850255478.xml · nonDerivative · entry 2 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,247 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:22 UTC |
MCCARTHY GLORIA MEVP & Chief Administrative Off
|
Tax withholdingCommon Stock | 617 | $469.03 | $289,391.51 |
DisclosureSEC source: 0001156039-23-000028 · wf-form4_167787850255478.xml · nonDerivative · entry 1 MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,114 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,786 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000027 · wf-form4_167787832892336.xml · derivative · entry 5 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,786 Underlying: Common Stock · 7,786 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 7,786 shares, and is exercisable in two installments of 2,595 shares each and one installment of 2,596 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
GrantCommon Stock | 2,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000027 · wf-form4_167787832892336.xml · nonDerivative · entry 3 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,725 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
GrantCommon Stock | 2,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000027 · wf-form4_167787832892336.xml · nonDerivative · entry 2 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,183 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 675 shares each on 3/1/2024 and 3/1/2025 and 676 shares on 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kendrick Charles Morgan JREVP & President, Commercial
|
Tax withholdingCommon Stock | 293 | $469.03 | $137,425.79 |
DisclosureSEC source: 0001156039-23-000027 · wf-form4_167787832892336.xml · nonDerivative · entry 1 Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,157 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:17 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,812 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000026 · wf-form4_167787821928724.xml · derivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,812 Underlying: Common Stock · 8,812 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:17 UTC |
Haytaian Peter DEVP & Pres Carelon & CarelonRx
|
GrantCommon Stock | 9,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000026 · wf-form4_167787821928724.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,362 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.